Acadia Will Outperform, Worth $48/Share Says Leerink By: Benzinga via Benzinga April 16, 2015 at 09:39 AM EDT In a report published Thursday, Leerink analysts initiated coverage of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) with an Outperform ... Read More >> Related Stocks: Acadia Pharmaceutica